HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edmour F Blouin Selected Research

Infections

12/2021Characterization of tick salivary gland and saliva alphagalactome reveals candidate alpha-gal syndrome disease biomarkers.
1/2015Identification and Characterization of Anaplasma phagocytophilum Proteins Involved in Infection of the Tick Vector, Ixodes scapularis.
2/2010The natural history of Anaplasma marginale.
1/2010Expression of Heat Shock and Other Stress Response Proteins in Ticks and Cultured Tick Cells in Response to Anaplasma spp. Infection and Heat Shock.
12/2008Differential expression of the tick protective antigen subolesin in anaplasma marginale- and A. phagocytophilum-infected host cells.
5/2008Advances toward understanding the molecular biology of the Anaplasma-tick interface.
9/2007Sp110 transcription is induced and required by Anaplasma phagocytophilum for infection of human promyelocytic cells.
10/2006Anaplasmosis: focusing on host-vector-pathogen interactions for vaccine development.
9/2005Capillary tube feeding system for studying tick-pathogen interactions of Dermacentor variabilis (Acari: Ixodidae) and Anaplasma marginale (Rickettsiales: Anaplasmataceae).
6/2005Genetic diversity of anaplasma species major surface proteins and implications for anaplasmosis serodiagnosis and vaccine development.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edmour F Blouin Research Topics

Disease

18Infections
12/2021 - 05/2002
12Tick Infestations
12/2021 - 03/2003
5Anaplasmosis
02/2010 - 07/2002
2Persistent Infection
02/2010 - 06/2005
2Tick-Borne Diseases (Tick-Borne Disease)
12/2008 - 09/2007
1red meat allergy
12/2021
1Hypersensitivity (Allergy)
12/2021
1Bacterial Infections (Bacterial Infection)
01/2013

Drug/Important Bio-Agent (IBA)

12VaccinesIBA
02/2010 - 03/2003
9Proteins (Proteins, Gene)FDA Link
12/2021 - 02/2003
6AntigensIBA
10/2006 - 10/2002
5Membrane Proteins (Integral Membrane Proteins)IBA
09/2005 - 12/2002
3Arthropod ProteinsIBA
02/2010 - 06/2005
3Recombinant ProteinsIBA
12/2006 - 02/2003
2Inactivated VaccinesIBA
02/2010 - 10/2002
2nucleotidaseIBA
11/2005 - 08/2005
2Merozoite Surface Protein 1 (MSA1)IBA
03/2004 - 02/2003
1Polysaccharides (Glycans)IBA
12/2021
1Biomarkers (Surrogate Marker)IBA
12/2021
1ProteomeIBA
01/2015
1NF-kappa B (NF-kB)IBA
01/2013
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2010
1Messenger RNA (mRNA)IBA
09/2007
1Complement System Proteins (Complement)IBA
09/2007
1Peptides (Polypeptides)IBA
08/2005
1Complementary DNA (cDNA)IBA
08/2005
1PolynucleotidesIBA
04/2005
1Amino AcidsFDA Link
03/2004
1Immune Sera (Antisera)IBA
02/2003
1AntibodiesIBA
02/2003
1Anti-Bacterial Agents (Antibiotics)IBA
07/2002
1Tetracycline (Achromycin)FDA LinkGeneric
07/2002
1Fluorescent Dyes (Fluorescent Probes)IBA
05/2002

Therapy/Procedure

1Enteral Nutrition (Feeding, Tube)
09/2005
1Nutritional Support (Artificial Feeding)
08/2005